| abstract |
The present disclosure describes compositions comprising at least one very long chain fatty acid chosen from C26+ acids (5n-3), prodrugs thereof, and pharmaceutically acceptable salts of any of the foregoing. The compositions are useful in methods for treating conditions associated with a loss of visual acuity including, for example, age-related macular degeneration. |